Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Feb;22(1):87–103. doi: 10.1111/j.1476-5381.1964.tb01546.x

Effect of hexadimethrine bromide on plasma kinin formation, hydrolysis of p-tosyl-l-arginine methyl ester and fibrinolysis

V Eisen
PMCID: PMC1703902  PMID: 14126061

Abstract

The antiheparin agent hexadimethrine bromide, in concentrations of 20 to 200 μg/ml., inhibited the activation by active Hageman factor of the plasma enzyme which releases kinin from substrate. Once activated, this kinin-forming enzyme was not consistently inhibited by hexadimethrine in a concentration of 1 mg/ml. Surfaces which induce kinin formation by activating Hageman factor in plasma (glass, kaolin, celite, barium carbonate and carboxymethylcellulose) were inactivated by bathing in aqueous solutions of hexadimethrine. The effects of hexadimethrine on Hageman factor and on glass were not abolished by amounts of heparin which neutralize most other actions of hexadimethrine. Hexadimethrine prevented the activation by kaolin, but not by streptokinase, of p-tosyl-L-arginine methyl ester-splitting and fibrinolytic factors in plasma; once these enzymes were activated by kaolin, they could not be inhibited by hexadimethrine. Hexadimethrine, given locally or intravenously into guinea-pigs, reduced the increase in capillary permeability produced by intracutaneous injections of kaolin suspensions.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ARMSTRONG D. A., STEWART J. W. Anti-heparin agents as inhibitors of plasma kinin formation. Nature. 1962 May 19;194:689–689. doi: 10.1038/194689a0. [DOI] [PubMed] [Google Scholar]
  3. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  4. BOTTI R. E., RATNOFF O. D. THE CLOT-PROMOTING EFFECT OF SOAPS OF LONG-CHAIN SATURATED FATTY ACIDS. J Clin Invest. 1963 Oct;42:1569–1577. doi: 10.1172/JCI104842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CONNOR W. E., HOAK J. C., WARNER E. D. Massive thrombosis produced by fatty acid infusion. J Clin Invest. 1963 Jun;42:860–866. doi: 10.1172/JCI104778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eisen V. Kinin formation and fibrinolysis in human plasma. J Physiol. 1963 May;166(3):514–529. doi: 10.1113/jphysiol.1963.sp007120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eisen V. Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation. J Physiol. 1963 May;166(3):496–513. doi: 10.1113/jphysiol.1963.sp007119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. IATRIDIS S. G., FERGUSON J. H. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. J Clin Invest. 1962 Jun;41:1277–1287. doi: 10.1172/JCI104590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. IATRIDIS S. G., FERGUSON J. H. Effect of surface and Hageman factor on the endogenous or spontaneous activation of the fibrinolytic system. Thromb Diath Haemorrh. 1961 Dec 15;6:411–423. [PubMed] [Google Scholar]
  10. KIMURA E. T., YOUNG P. R., STEIN R. J., RICHARDS R. K. Some pharmacologic characteristics of hexadimethrine bromide (polybrene); a new antiheparin agent. Toxicology. 1959 Mar;1(2):185–202. doi: 10.1016/0041-008x(59)90139-5. [DOI] [PubMed] [Google Scholar]
  11. KOCH W. Relationship between air temperature and mean radiant temperature in thermal comfort. Nature. 1962 Nov 10;196:587–587. doi: 10.1038/196587a0. [DOI] [PubMed] [Google Scholar]
  12. LASSEN M. The esterase activity of the fibrinolytic system. Biochem J. 1958 Jul;69(3):360–366. doi: 10.1042/bj0690360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MACKAY M., MAYCOCK W. D., COMBRIDGE B. S. Activation of endogenous plasma proteolytic enzymes with the consequent production of pharmacologically active polypeptides. Nature. 1962 Sep 22;195:1206–1207. doi: 10.1038/1951206a0. [DOI] [PubMed] [Google Scholar]
  14. MARGOLIS J. Activation of Hagemen Factor by saturated fatty acids. Aust J Exp Biol Med Sci. 1962 Dec;40:505–513. doi: 10.1038/icb.1962.54. [DOI] [PubMed] [Google Scholar]
  15. MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MARGOLIS J. The interrelationship of coagulation of plasma and release of peptides. Ann N Y Acad Sci. 1963 Feb 4;104:133–145. doi: 10.1111/j.1749-6632.1963.tb17659.x. [DOI] [PubMed] [Google Scholar]
  17. MARGOLIS J. The mode of action of Hageman factor in the release of plasma kinin. J Physiol. 1960 May;151:238–252. doi: 10.1113/jphysiol.1960.sp006434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
  19. RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  21. ROBERTS P. S. Measurement of the rate of plasmin action on synthetic substrates. J Biol Chem. 1958 May;232(1):285–291. [PubMed] [Google Scholar]
  22. SHANBERGE J. N., REGAN E. E., TALARICO L., BUSIEK B. The effect of Polybrene on blood coagulation. In vitro. J Lab Clin Med. 1961 Jul;58:23–33. [PubMed] [Google Scholar]
  23. SOULIER J. P., PROU-WARTELLE O. [New data on the Hageman and P.T.A. factors and on the "contact"]. Rev Fr Etud Clin Biol. 1959 Nov;4:932–938. [PubMed] [Google Scholar]
  24. WEBSTER M. E., PIERCE J. V. Studies on plasma kallikrein and its relationship to plasmin. J Pharmacol Exp Ther. 1960 Dec;130:484–491. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES